Percentage of patients age 50 and over with fragility fracture who have had appropriate laboratory investigation for secondary causes of fracture ordered or performed prior to discharge from inpatient status.
Percentage of surgical pathology reports for primary colorectal, endometrial, gastroesophageal or small bowel carcinoma, biopsy or resection, that contain impression or conclusion of or recommendation for testing of mismatch repair (MMR) by immunohistochemistry (biomarkers MLH1, MSH2, MSH6, and PMS2), or microsatellite instability (MSI) by DNA-based testing status, or both
The percentage of patients 18-75 years of age who had a diagnosis of type 1 or type 2 diabetes and whose diabetes was optimally managed during the measurement period as defined by achieving ALL of the following:
• HbA1c less than 8.0 mg/dL
• Blood Pressure less than 140/90 mmHg
• On a statin medication, unless allowed contraindications or exceptions are present
• Non-tobacco user
• Patient with ischemic vascular disease is on daily aspirin or anti-platelets, unless allowed contraindications or exceptions are present
The percentage of women age 50-85 who suffered a fracture and who either had a bone mineral density test or received a prescription for a drug to treat osteoporosis.
The percentage of women 65-85 years of age who report ever having received a bone density test to check for osteoporosis.
This measure estimates the rate of emergency department visits for children ages 3 – 21 who are being managed for identifiable asthma, using specified definitions. The measure is reported in visits per 100 child-years.
Percentage of persons > 13 years of age with diagnosed HIV infection who are virally suppressed in the measurement year.
Following the project committtee measure evaluation meeting, a meeting summary of the committee's deliberation and endorsement recommendations is posted for public comment. Comments received will be reviewed by the project committee during the post-comment meeting.
After the measure submission deadline, the measures submitted for endorsement review are posted to the PQM website for public comment. These comments are aggregated and shared with the project committee for consideration during the measure evaluaiton meeting.